SCHEMBL23672605

SCHEMBL23672605

Cc1nc(-c2ccc(Cc3cc(C(=O)NC4CN(C(C)(C)C)C4)nc4ccsc34)cc2)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ CHRM1 P11229 2/20 0.38
▸ NPC1 O15118 9/20 0.37
▸ RAB9A P51151 9/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ PAX8 Q06710 1/20 0.36
▸ KLF5 Q13887 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ BLM P54132 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ STAT1 P42224 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23672660 0.88 CHRM1 (0.45) CHRM1ADORA2AADORA2B
SCHEMBL23672933 0.88 CHRM1 (0.43) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672690 0.87 NPC1 (0.44) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672583 0.87 KDM4E (0.39) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672657 0.86 CHRNB2 (0.41) ALDH1A1CHRM1NPC1RAB9ASMN1; SMN2
SCHEMBL23672670 0.86 CHRM1 (0.51) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672899 0.85 NPC1 (0.41) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672812 0.85 CHRM1 (0.46) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672639 0.85 CHRM1 (0.46) KDM4EALDH1A1CHRM1NPC1RAB9A
SCHEMBL23672730 0.83 CHRM1 (0.45) CHRM1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111251-B2 Positive allosteric modulators of the muscarinic acetylcholine receptor M1 VANDERBILT UNIVERSITY (US) 2021-09-07 — — US claimed
US-20210230180-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY 2021-07-29 — — US claimed
EP-3416639-B1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 UNIV VANDERBILT (US) 2022-06-08 — — EP disclosed
US-20210230180-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY 2021-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230180-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 CHRM1, CHRM2, CHRM4 KDM4E 1530/4885ALDH1A1 3782/4885CHRM1 1/4885
US-11111251-B2 Positive allosteric modulators of the muscarinic acetylcholine receptor M1 CHRM1, CHRM2, CHRM4 KDM4E 1530/4885ALDH1A1 3782/4885CHRM1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback